Search
+
    SEARCHED FOR:

    RE RATING

    Fundamental Radar I What factors have driven a re-rating of Supreme Industries? Pankaj Kumar explains

    Fundamental Radar I What factors have driven a re-rating of Supreme Industries? Pankaj Kumar explains

    Supreme Industries has outperformed industry growth and gained market share in the plastic piping division. Robust volume performance in the piping business, with strong margins and continuous focus on strengthening product offerings, has led to the...

    Fundamental Radar I Why is Hero MotoCorp well placed to see further re-rating? Vikram Kasat explains

    Fundamental Radar I Why is Hero MotoCorp well placed to see further re-rating? Vikram Kasat explains

    Likely recovery in rural market, strong demand for premium bikes, expansion of electric vehicle portfolio, and capacity build-up in parts accessories & merchandise (PAM) business are likely to put Hero MotoCorp on a good stead and improve re-rating p...

    Fundamental Radar: Why is Hero MotoCorp best placed in 2-wheeler space to see a re-rating? Sneha Poddar explains

    Fundamental Radar: Why is Hero MotoCorp best placed in 2-wheeler space to see a re-rating? Sneha Poddar explains

    The domestic two-wheeler demand saw a strong rebound during the 33 days of festival period this year. Hero MotoCorp should benefit the most from this recovery given its strong presence in key northern and eastern states like UP, Rajasthan...

    Fundamental Radar: JK Paper poised for a re-rating on strong business prospects

    Fundamental Radar: JK Paper poised for a re-rating on strong business prospects

    Major paper companies have entered the next phase of expansion due to high-capacity utilization and strong balance sheet position, which provides good upside potential to the stock from FY26-27 perspective, says Sandeep Raina of Nuvama Professional Clients Group. Fundame...

    Fundamental Radar I Why does Piramal Pharma stock deserve a re-rating? Sandeep Raina explains

    Fundamental Radar I Why does Piramal Pharma stock deserve a re-rating? Sandeep Raina explains

    Piramal Pharma has a diversified business encompassing contract development and manufacturing business (CDMO), complex hospital generics (CHG), and India consumer healthcare (ICH). The CDMO business is grossly undervalued considering its potential in niche ...

    Fundamental Radar: What’s likely to drive further re-rating for SBI? Sneha Poddar explains

    Fundamental Radar: What’s likely to drive further re-rating for SBI? Sneha Poddar explains

    State Bank of India’s robust performance has been aided by strong loan growth and lower provisions. The asset quality performance remains strong with consistent improvements in headline asset quality ratios. The lender is seen delivering RoA/RoE of 1.1%/18.3% ...

    The Economic Times
    BACK TO TOP
    Advertisement